Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

<strong>Introduction <br></strong>There is an urgent need to determine the safety, effectiveness and cost-effectiveness of novel antiviral treatments for COVID-19 in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. <br><stron...

Full description

Bibliographic Details
Main Authors:	Gbinigie, O, Ogburn, E, Allen, J, Dorward, J, Dobson, M, Madden, T-A, Yu, L-M, Lowe, DM, Rahman, N, Petrou, S, Richards, D, Hood, K, Patel, M, Saville, BR, Marion, J, Holmes, J, Png, ME, Hayward, G, Lown, M, Harris, V, Jani, B, Hart, N, Khoo, S, Rutter, H, Chalk, J, Standing, JF, Breuer, J, Lavallee, L, Hadley, E, Cureton, L, Benysek, M, Andersson, MI, Francis, N, Thomas, NPB, Evans, P, van Hecke, O, Koshkouei, M, Coates, M, Barrett, S, Bateman, C, Davies, J, Raymundo-Wood, I, Ustianowski, A, Nguyen-Van-Tam, J, Carson-Stevens, A, Hobbs, R, Little, P, Butler, CC
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2023

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

Similar Items